Development of a genome-wide CRISPR screen in CD4+ T cells to identify drug targets for immune-mediated inflammatory diseases

2021-04-13T17:39:43+00:00April 12th, 2021|Comments Off on Development of a genome-wide CRISPR screen in CD4+ T cells to identify drug targets for immune-mediated inflammatory diseases

Scalable Manufacturing and Nanovesicle Delivery of CRISPR-Cas9 Ribonucleoproteins Using a cGMP- Compliant Cell Engineering Platform

2021-03-24T15:37:30+00:00November 2nd, 2020|Comments Off on Scalable Manufacturing and Nanovesicle Delivery of CRISPR-Cas9 Ribonucleoproteins Using a cGMP- Compliant Cell Engineering Platform

CRISPR-mediated Mutation Correction of Hematopoietic Stem Cells from Patients with X-linked Chronic Granulomatous Disease Using Non-Viral Cell Engineering

2020-07-07T16:05:23+00:00May 16th, 2020|Comments Off on CRISPR-mediated Mutation Correction of Hematopoietic Stem Cells from Patients with X-linked Chronic Granulomatous Disease Using Non-Viral Cell Engineering

Streamlining HTS: Ion Channel, GPCR, and Transporter Assays in Biologically Relevant Cells using Large Scale Transfection

2020-07-07T19:14:16+00:00May 12th, 2020|Comments Off on Streamlining HTS: Ion Channel, GPCR, and Transporter Assays in Biologically Relevant Cells using Large Scale Transfection

Large Scale, CHO Transient Transfection and Rapid Generation of CHO Stable Clones: >1 gram/Liter Antibody Titers Within 2 Weeks and High Yield Stable Clones in Under 8 Weeks.

2020-07-07T19:15:45+00:00May 12th, 2020|0 Comments
Go to Top